Welcome to our dedicated page for Zepp Health news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health stock.
Zepp Health Corporation reports developments in smart wearables and health technology through its NYSE-listed ADRs. The company’s updates center on Amazfit smartwatches and fitness devices, including performance running, rugged outdoor and active-lifestyle product lines, as well as Zepp Clarity and Zepp Aura consumer health brands.
Recurring news themes include Amazfit product introductions, connected training features, biometric and recovery tools, Zepp OS and related platform technology, brand partnerships in fitness communities, unaudited financial results, share repurchase and debt-management commentary, and annual Form 20-F reporting for the foreign private issuer.
Zepp Health Corp. (NYSE: ZEPP) announced a strategic shift to Amazon Web Services (AWS) for its IT infrastructure, enhancing its operations across 70 countries and supporting 38 million wearable device users. The partnership aims to leverage AWS's robust security, compliance, and scalable cloud solutions to accelerate the development of next-generation smart health devices. In 2020, Zepp Health shipped 46 million units, focusing on data analytics for health management. This move also prioritizes user data security with AWS’s encryption capabilities, reinforcing Zepp Health's commitment to data privacy.
On March 17, 2021, Zepp, a leader in wearable technology, celebrates World Sleep Day as a Diamond sponsor, aiming to promote healthy sleep practices worldwide. Zepp launches an interactive Lullaby Generator on www.ZeppLullaby.com, encouraging users to create personalized lullabies. The initiative follows the Zepp Global Sleep Report, revealing 89% of 12,000 respondents believe calming music aids sleep, with Beethoven's Moonlight Sonata as the favorite. Expert tips emphasize natural light exposure, regular exercise, and relaxation methods for achieving better sleep.
Zepp Health Corp. (NYSE: ZEPP) reported fourth-quarter revenue of RMB2.0 billion (US$302.3 million), a slight decrease from the previous year, largely due to a 20.8% drop in revenue from Xiaomi products. However, self-branded products saw a notable growth of 25.1%, contributing positively to overall performance. Gross margin declined to 19% from 23.8%, affected by product mix and discounting strategies. The company expects strong performance in 2021 with projected revenues for Q1 between RMB1.0 billion and RMB1.15 billion.
Zepp Health Corp. (NYSE: ZEPP) has expanded its agreement with Rouumtech Co., Ltd. to private label a customized Europa™ portable X-ray system and its entire range of X-ray products for sales in China. The collaboration builds on a relationship established in August 2020 and aims to obtain China market clearance from the National Medical Products Administration. Zepp Health will leverage its AI expertise alongside Rouumtech's medical imaging technologies to enhance medical care globally.
Zepp Health Corp., a leading provider of smart wearable technology, will report its fourth quarter and full year 2020 unaudited financial results on March 15, 2021, before market opening. Management will hold a conference call at 8:00 a.m. Eastern Time on the same day, with access available via multiple dialing options. The company aims to connect health with technology, having shipped 36.6 million units in 2019, representing 23% of global shipments. More details can be found on their website.